These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25881304)

  • 1. The carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studies.
    Chen LX; Ning GZ; Zhou ZR; Li YL; Zhang D; Wu QL; Zhang TS; Cheng L; Feng SQ
    PLoS One; 2015; 10(4):e0123080. PubMed ID: 25881304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study.
    Lee WY; Sun LM; Lin MC; Liang JA; Chang SN; Sung FC; Muo CH; Kao CH
    PLoS One; 2012; 7(12):e53032. PubMed ID: 23300854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate.
    Lu PY; Hsieh CF; Tsai YW; Huang WF
    Clin Ther; 2011 Sep; 33(9):1173-9. PubMed ID: 21849210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal and gastric cancer incidence and mortality in alendronate users.
    Abrahamsen B; Pazianas M; Eiken P; Russell RG; Eastell R
    J Bone Miner Res; 2012 Mar; 27(3):679-86. PubMed ID: 22113985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study.
    Chiang CH; Huang CC; Chan WL; Huang PH; Chen TJ; Chung CM; Lin SJ; Chen JW; Leu HB
    J Bone Miner Res; 2012 Sep; 27(9):1951-8. PubMed ID: 22532232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of gastrointestinal cancer in users of bisphosphonates and other antiresorptive drugs against osteoporosis.
    Vestergaard P
    Calcif Tissue Int; 2011 Dec; 89(6):434-41. PubMed ID: 22002678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
    N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?
    Vestergaard P
    Calcif Tissue Int; 2012 Jan; 90(1):22-9. PubMed ID: 22120197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bisphosphonates and incidence of cancers in patients with osteoporosis: a systematic review and meta-analysis.
    Deng Y; Zhang Z; Jia X; Cheng W; Zhou X; Liu Y; Wang M
    Arch Osteoporos; 2018 Dec; 14(1):1. PubMed ID: 30560459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Long-Term Anti-Osteoporotic Treatment Associated with Greater Risk of Cancer in People with Severe Vertebral Fractures? A Hospital-Based Cohort Study.
    Chen YC; Su FM; Cheng TT; Lai HM; Yu SF
    J Am Geriatr Soc; 2015 Nov; 63(11):2418-9. PubMed ID: 26603069
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer risk in patients treated with denosumab compared with alendronate: A population-based cohort study.
    Yahyavi SK; Holt R; Knudsen NK; Andreassen CH; Sejling C; Meddis A; Kjaer SK; Schwarz P; Jensen JB; Torp-Pedersen C; Juul A; Selmer C; Blomberg Jensen M
    Bone; 2024 May; 182():117053. PubMed ID: 38395247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk of venous thromboembolism among Taiwan osteoporotic fracture population under osteoporosis pharmacological treatments.
    Lin TC; Lee CH; Yang CY; Yang YH; Lin SJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1599-607. PubMed ID: 24606074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.
    Sun K; Liu JM; Sun HX; Lu N; Ning G
    Osteoporos Int; 2013 Jan; 24(1):279-86. PubMed ID: 23052941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study.
    Klotz LH; McNeill IY; Kebabdjian M; Zhang L; Chin JL;
    Eur Urol; 2013 May; 63(5):927-35. PubMed ID: 23040208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.
    Orimo H; Nakamura T; Fukunaga M; Ohta H; Hosoi T; Uemura Y; Kuroda T; Miyakawa N; Ohashi Y; Shiraki M;
    Curr Med Res Opin; 2011 Jun; 27(6):1273-84. PubMed ID: 21554143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis.
    Landfeldt E; Ström O
    Bone; 2012 Oct; 51(4):637-42. PubMed ID: 22842329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis.
    Ringe JD; Schacht E; Dukas L; Mazor Z
    Arzneimittelforschung; 2011; 61(2):104-11. PubMed ID: 21428245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.
    Chiu WY; Yang WS; Chien JY; Lee JJ; Tsai KS
    PLoS One; 2018; 13(4):e0196419. PubMed ID: 29694412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid Hormone Plus Alendronate in Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Wang C; Zhang G; Gu M; Fan J; Chen J; Zhang G; Li B
    J Invest Surg; 2015; 28(6):309-16. PubMed ID: 26270229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.